Apiam Animal Health Valuation

Is AHX undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of AHX when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: AHX (A$0.4) is trading below our estimate of fair value (A$1.77)

Significantly Below Fair Value: AHX is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for AHX?

Key metric: As AHX is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for AHX. This is calculated by dividing AHX's market cap by their current earnings.
What is AHX's PE Ratio?
PE Ratio	14.6x
Earnings	AU$4.93m
Market Cap	AU$72.10m

AHX key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	0.8x
Enterprise Value/EBITDA	8.8x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does AHX's PE Ratio compare to its peers?

The above table shows the PE ratio for AHX vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	26.1x
SLA SILK Laser Australia	24.5x	28.9%	AU$177.4m
HLA Healthia	46.1x	n/a	AU$252.1m
ACL Australian Clinical Labs	29.1x	16.0%	AU$697.5m
FCG Freedom Care Group Holdings	4.5x	n/a	AU$4.0m
AHX Apiam Animal Health	14.6x	n/a	AU$72.1m

Price-To-Earnings vs Peers: AHX is good value based on its Price-To-Earnings Ratio (14.6x) compared to the peer average (20x).

Price to Earnings Ratio vs Industry

How does AHX's PE Ratio compare vs other companies in the Global Healthcare Industry?

11 Companies	Price / Earnings	Estimated Growth	Market Cap

11 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: AHX is good value based on its Price-To-Earnings Ratio (14.6x) compared to the Global Healthcare industry average (20.6x).

Price to Earnings Ratio vs Fair Ratio

What is AHX's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

AHX PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	14.6x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate AHX's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Doctor Care Anywhere Group

AU$23.5m

Provides digital healthcare and development services in the United Kingdom, Australia, and the Republic of Ireland.

DOC

AU$0.064

-4.5%

33.3%

CardieX

AU$30.9m

Engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific.

CDX

AU$0.10

-22.2%

n/a

Cogstate

AU$166.4m

A neuroscience technology company, engages in the creation, validation, and commercialization of digital brain health assessments used in both academic and industry sponsored research.

CGS

AU$0.96

-2.5%

-36.9%